These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 2794994

  • 1. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M, Nardi AE, Mundim FD, Alves AB.
    J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
    [Abstract] [Full Text] [Related]

  • 2. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 3. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D, Wiens A, Ellis J, Alda M, Lapierre Y.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [Abstract] [Full Text] [Related]

  • 4. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L, Evrard JL, Gilles C, Stenier P, Wolfrum C.
    Acta Psychiatr Belg; 1992 Sep; 92(6):355-69. PubMed ID: 1345409
    [Abstract] [Full Text] [Related]

  • 5. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990 Sep; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S, Turkçapar MH, Ozturk Kiliç EZ, Demirergi N, Akdemir A, Sirin A, Ozbay MH.
    Acta Psychiatr Belg; 1995 Sep; 95(3):139-51. PubMed ID: 8525856
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Sep; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M, Guelfi JD.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [Abstract] [Full Text] [Related]

  • 9. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M, Amrein R, Stabl M.
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
    Versiani M, Oggero U, Alterwain P, Capponi R, Dajas F, Heinze-Martin G, Marquez CA, Poleo MA, Rivero-Almanzor LE, Rossel L.
    Br J Psychiatry Suppl; 1989 Oct; (6):72-7. PubMed ID: 2695129
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F, Wolfersdorf M.
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K, Berger M.
    Acta Psychiatr Scand Suppl; 1990 May; 360():59-60. PubMed ID: 2248074
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
    Hebenstreit GF, Loidl M, Baumhackl U, Gallhofer B, Geretsegger C, Radmayr E, Saletu M, Schöny W, Stabl M.
    J Neural Transm Suppl; 1990 May; 32():177-84. PubMed ID: 2089087
    [Abstract] [Full Text] [Related]

  • 14. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M, Moll E.
    Acta Psychiatr Scand Suppl; 1990 May; 360():43. PubMed ID: 2248067
    [Abstract] [Full Text] [Related]

  • 15. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 May; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 16. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996 May; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 17. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994 May; 9(2):109-13. PubMed ID: 8056992
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U, Bizière K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M.
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
    Rimón R, Jääskeläinen J, Kaartinen P, Kalli A, Kilponen E, Koskinen T, Nikkilä H, Pirttiperä V, Seppälä J.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
    [Abstract] [Full Text] [Related]

  • 20. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.